He is Past-President of both the American Society of Retina Specialists (ASRS), the largest organization of retina specialists in the world, and the Foundation of the ASRS, which supports patients and the retina community through education, awareness, and fundraising. Pollack has held a number of national leadership positions and received many honors. He completed his ophthalmology residency at Washington University and his retina fellowship at the Medical College of Wisconsin, in Milwaukee.ĭr. He received his undergraduate degree at Washington University in St. Pollack’s passion for ophthalmology was inspired by his father, who was also an ophthalmologist. He sees patients in our Joliet and Hinsdale locations.ĭr. A recognized leader and innovator in the field of retina, he has delivered over 200 scientific presentations across the globe and has published over 60 scientific papers and book chapters. Pollack has been with Illinois Retina Associates and Rush University Medical Center since 1997. Retinal Detachment Treatment in Illinoisĭr.These studies were terminated early because of safety concerns related to retinal detachments and retinal tears.Ĭ(3)F(8) DRCR Retina Network Pneumatic vitreolysis Vitreomacular traction macular hole.Ĭopyright © 2021 American Academy of Ophthalmology. In eyes with FTMH, PVL resulted in hole closure in approximately one third of eyes. In most eyes with VMT, PVL induced hyaloid release. The mean change in VA from baseline at 8 weeks was -1.5 letters (95% CI, -10.3 to 7.3 letters). In Protocol AH, 10 of 35 eyes (29% ) achieved FTMH closure without rescue vitrectomy at 8 weeks. The mean change in VA from baseline at 24 weeks was 6.7 letters in the PVL group and 6.1 letters in the sham group (adjusted difference, -0.8 P = 0.77). At 24 weeks in Protocol AG, 18 of 23 eyes in the PVL group (78%) versus 2 of 22 eyes in the sham group (9%) achieved central VMT release without rescue vitrectomy (adjusted risk difference, 66% P< 0.001). Combining studies, 7 of 59 eyes (12% 2 eyes in Protocol AG, 5 eyes in Protocol AH) that received PVL developed rhegmatogenous retinal detachment (n = 6) or retinal tear (n = 1). Higher than expected rates of retinal detachment and tear resulted in early termination of both protocols. Pneumatic vitreolysis using perfluoropropane (C 3F 8) gas.Ĭentral VMT release at 24 weeks (Protocol AG) and FTMH closure at 8 weeks (Protocol AH).įrom October 2018 through February 2020, 46 participants were enrolled in Protocol AG, and 35 were enrolled in Protocol AH. In Protocol AH, eyes had a FTMH (≤250 μm at the narrowest point) and VA of 20/25 to 20/400. In Protocol AG, visual acuity (VA) was 20/32 to 20/400. Participants were adults with central VMT (vitreomacular adhesion was ≤3000 μm). Two multicenter (28 sites) studies: a randomized clinical trial comparing PVL with observation (sham injection) for VMT without FTMH (Protocol AG) and a single-arm study assessing PVL for FTMH (Protocol AH). To evaluate pneumatic vitreolysis (PVL) in eyes with vitreomacular traction (VMT) with and without full-thickness macular hole (FTMH).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |